Vaccine production capacity is often limited by the number of available eggs.Protein Sciences uses a method in which it extracts a gene from a flu virus and places it into an insect virus called baculovirus, which is harmless to humans.The virus quickly multiplies inside insect cells, which are then purified to become a basic part of a human vaccine.The company said last week it had started working on an H1N1 vaccine using that method and estimated it could make 100,000 doses a week.Drug companies are racing to meet the global demand for vaccines that will be needed to protect against H1N1. Three creditors filed a petition on Monday in Delaware court seeking to force the company into involuntary bankruptcy.With conventional methods, vaccine makers germinate a flu virus in fertilized chicken eggs in a process that can take four to six months. government is investing in a new technique for making flu vaccines that it hopes will help the nation respond quickly to outbreaks such as the H1N1 swine flu virus. CHICAGO (Reuters) – The U.S. The company is not required to update itsforward-looking statements.Contact:Magnum D’Or Resources, Inc.,Fort Lauderdale, FL1-305-420-6563 D’Or Resources, Inc.Magnum D’Or Resources, Inc., +1-305-420-6563, . The results anticipated by any or all of these forward-lookingstatements may not occur.

Furthermore, the reason why ourclients will prefer to use Magnum/SRI compounds is they will be able to enjoya substantial and meaningful reduction in raw material cost withoutcompromising product performance and quality. The reason why Magnum/SRI premium compounds are one of a kind is because theycan be substituted in high specification compound applications withoutappreciable loss in properties or performance. This also includes maximizing cost savings forclients while producing high quality materials. This willallow production of higher yielding compounds which will potentially createhigher revenues and profits.

Magnum/SRI tests aretargeting premium applications that contain high grade properties. The Company is alsocarrying out a number of trials on various compound blends specificallytargeted at high specification premium applications. Magnum’s proprietary “GREEN” technologyprovides a one of a kind solution to all of the challenges in eliminatingStockpiles of Scrap Tires and Rubber Scrap including: establishing TurnkeyRecycling facilities; design, manufacture, and sell products made withrecycled materials; and institute viable solutions to the problem of recyclingwaste rubber.Magnum/SRI are currently using their advanced technologies to produce nextgeneration rubber recycling solutions for custom compounds, retread compounds,processing aids, advanced state-of-the-art equipment, and reactivatedambient/cryogenic rubber powders for the global market. Magnumcurrently holds over $130 Million USD in open contracts for the production ofrubber nuggets and rubber buffing.